14 May 2022  (23:07-UTC-07 Tango 06) 24 Ordibehest 1401/12 Shawwal 1443/14 Yi-Si 4720

 

The U.S. Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department is funding MIT (Massachusetts Institute of Technology) to develop Artificial Intelligence (A-I) and other so-called deep learning technologies in order to fast-forward scientific data regarding Pandemic treatments, especially the use of Remdesivir (aka Veklury) in drug ‘cocktails’.  Believe it or not, this is a result of an order by the administration of United States President Joseph R. Biden Junior.

The DTRA also admitted that a horse drug called Molnupiravir, created to treat Venezuelan Equine Encephalitis, was used in treating humans for The Pandemic, and it work well as a “repurposed” drug for humans! Repurposing drugs for the current Pandemic, and future pandemics, involves combining them with other drugs. The DTRA hopes a new A-I/deep learning system will speed that process up greatly.

MIT has already been conducting their own A-I/deep learning for repurposing drugs for Pandemic use (Deep learning identifies synergistic drug combinations for treating COVID-19).  MIT is using a deep learning system called ComboNet.

Drugs that play well with each other are called synergistic drugs. The biggest advantages of synergistic drugs is lower doses with much better results. ComboNet discovered that Remdesivir works even better as a synergistic drug!

ComboNet has already suggested mixing Remdesivir with Reserpine (high blood pressure treatment), or with IQ-1S (an experimental JNK Inhibitor, used to treat cancer cells).

The U.S. Food & Drug Administration recent approved Remdesivir for people aged 28 days (not years, days) and older with mild to moderate Pandemic infection, hospitalized or not.

Operation Jupiter: PANDEMIC LOGISTIC SHENANIGANS HIT U.S. MILITARY NANO-VAX OPERATIONS!

EVIDENCE CAPTURED IN UKRAINE REVEALS MASSIVE U.S. LED GLOBAL BIOLOGICAL WARFARE OP! I’VE BEEN WARNING ABOUT THIS SINCE 2015!